Table 2 Prevalence of autoantibodies and previously diagnosed autoimmune diseases among recruited PID patients
From: Assessment of autoantibodies in paediatric population with primary immunodeficiencies: a pilot study
Type of PID (n = 58) | Previous diagnosis of autoimmune disease | Presence of autoantibodies |
|---|---|---|
Combined immunodeficiency with associated or syndromic features (CID; n = 5) | 0.00% (n = 0) | 20% (n = 1) |
Predominantly antibody deficiency* (PAD; n = 46) | 8.7% (n = 4) | 21.74% (n = 10) |
Congenital defects of phagocyte number, function or both (n = 3) | 0.00% (n = 0) | 33.33% (n = 1) |
Complement deficiency (n = 2) | 0.00% (n = 0) | 0.00% (n = 0) |
Others** (n = 2) | 50.00% (n = 1) | 100.00% (n = 2) |